4
Changes in Ownership
Atea Pharmaceuticals, Inc. Filed Acc 0001193125-26-279728
Director acquired 29,600 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Lucidi Bruno Director | 2026-06-18 | Option exercise | +29,600 | 142,350 | D | ||
| Derivatives | |||||||
| Lucidi Bruno Director | 2026-06-18 | Option exercise · Restricted Stock Units | −29,600 | 0 | D | ||
| Lucidi Bruno Director | 2026-06-18 | Grant or award · Restricted Stock Units | +26,700 | 26,700 | D | ||
| Lucidi Bruno Director | 2026-06-18 | Grant or award · Stock Option (Right to Buy) | +37,700 | 37,700 | D | ||
Loading xslF345X06/ownership.xml…